← Back to directory
AC
Addor Capital
Nanjing, Jiangsu, ChinaWebsite ↗
Addor Capital is a Chinese investment firm founded in 2014, backed by the Jiangsu High-Tech Investment Group, a state-owned investment company. It is recognized as a growth capital firm and one of China's most influential investment institutions, focusing on various industries including technology, manufacturing, energy, and healthcare.
Last raised
Jul 2025
1y 2mo ago
Latest fund size
$137M
Nanjing Govtor Addor Strategic Emerging Industry Software and Information Equity Investment Fund Partnership (Limited Partnership)
AUM
$17.6B
estimated
Funds raised
Capital this firm has raised, newest first
Nanjing Govtor Addor Strategic Emerging Industry Software and Information Equity Investment Fund Partnership (Limited Partnership)
Jul 2025
$137M
Addor Capital Health Achievement Fund II
Jan 2021
—
Unnamed fund for emerging technology startups
Sep 2020
$146M
Unnamed fund for start-ups in Eastern China's Nanjing City
Jul 2019
$145M
Fuzhou Rongjin Digital Investment Fund
Jan 2019
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Tripo AI | Series A | $150M | Jul 2026 | |
| Zejun Pharmaceutical | — | — | Apr 2026 | |
| Medaesthe Medical | — | — | Jul 2025 | |
| Astra OptoelectronicsLead | Seed | — | May 2025 | |
| Shuizhiguo | — | — | Apr 2025 | |
| Kangweijian Biotechnology | — | — | Aug 2024 | |
| Challenbio | — | — | Mar 2024 | |
| Seesheen | — | — | Mar 2024 |
Sources
Where this data came from